Leaflet CO-KARBIS 16mg / 2.5mg tablets

Product code:
W70913012
Quantity:
28
Indicated for:
hypertension
Route of administration:
oral
Substance:
candesartan cilexetil + indapamide (antihypertensive + diuretic)
ATC
C09DA06 — Cardiovascular system | Angiotensin II receptor blockers (ARBs), combinations | Angiotensin ii receptor blockers (arbs) and diuretics

Precautions:

Dose adjustment in renal impairment

Dose adjustment may be needed in kidney disease.

Dizziness / vertigo

This medicine may cause dizziness or vertigo.

Contraindicated during pregnancy

Do not use this medicine during pregnancy.

Hypotension / fall risk

May lower blood pressure and increase the risk of falls.

Major drug interactions

This medicine may have important interactions with other medicines.

Requires periodic laboratory tests

Periodic laboratory tests may be required during treatment.

Electrolyte disturbances

This medicine may change blood electrolyte levels.

Candesartan cilexetil and indapamide are used together for the treatment of high blood pressure, providing more effective blood pressure control. This combination combines an angiotensin II receptor antagonist (candesartan) and a thiazide-like diuretic (indapamide).

Candesartan helps relax blood vessels, while indapamide reduces blood volume by increasing the elimination of water and salt through urine. This leads to lower blood pressure and a reduced risk of cardiovascular complications.

The medication is taken orally, usually once daily, as directed by a doctor. It is important to monitor blood pressure and electrolyte levels during treatment.

Side effects may include dizziness, fatigue, electrolyte imbalances, or, in rare cases, allergic reactions. Patients should inform their doctor of any unusual symptoms.

General data about CO-KARBIS 16mg / 2.5mg

Substance:
candesartan cilexetil + indapamide
Date of latest medicines list:
01-06-2026
Product code:
W70913012
Concentration:
16mg / 2.5mg
Pharmaceutical form:
tablets
Quantity:
28
Product type:
Generic medicine
Price:
37.46 RON
Prescription status:
P-6L — Medicines dispensed with a medical prescription that is not retained by the pharmacy and may be renewed; the prescription may be used for 6 months from the date of issue.

Marketing authorisation

Manufacturer:
KRKA D.D., NOVO MESTO - SLOVENIA
Holder:
KRKA, D.D., NOVO MESTO - SLOVENIA
Number:
15815/2025/12
Shelf life:
2 years

Concentrations available for candesartan cilexetil + indapamide

  • 16mg/2.5mg
  • 8mg/2.5mg

Compensation lists for CO-KARBIS 16mg / 2.5mg KRKA

D - Sublist D with 20% discount from the reference price

Price
37.46 RON
Copayment
7.49 RON
Patient
29.97 RON